Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2007

01-05-2007 | Epidemiology

Changes in risk of death from breast cancer with season and latitude

Sun exposure and breast cancer survival in Norway

Authors: Alina Carmen Porojnicu, Zoya Lagunova, Trude Eid Robsahm, Jens Petter Berg, Arne Dahlback, Johan Moan

Published in: Breast Cancer Research and Treatment | Issue 3/2007

Login to get access
Metadata
Title
Changes in risk of death from breast cancer with season and latitude
Sun exposure and breast cancer survival in Norway
Authors
Alina Carmen Porojnicu
Zoya Lagunova
Trude Eid Robsahm
Jens Petter Berg
Arne Dahlback
Johan Moan
Publication date
01-05-2007
Published in
Breast Cancer Research and Treatment / Issue 3/2007
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9331-8

Other articles of this Issue 3/2007

Breast Cancer Research and Treatment 3/2007 Go to the issue

Clinical Trial

Pectoral stretching program for women undergoing radiotherapy for breast cancer

Preclinical Study

15-Deoxy-Δ12,14-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression

Epidemiology

Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center?

Clinical Trial

Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients

Clinical Trial

Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer

Epidemiology

Reproductive factors and breast cancer risk among older women

2024 ASCO Annual Meeting Coverage

Highlights of the Day: Breast cancer – metastatic

Breast Cancer Video

In this session, Dr. Wolff provides his key takeaways from the data presented in the metastatic breast cancer oral abstract session at ASCO 2024.

Watch now

Highlights of the Day: Gynecologic cancer

Gynecologic Cancer Video

Highlights of the Day: Breast Cancer – local/regional/adjuvant

Breast Cancer Video

Neoadjuvant dual immunotherapy improves melanoma outcomes

04-06-2024 Melanoma News

» View more highlights on the ASCO 2024 congress hub page

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits